… In conclusion, the development of the RTS, S/A01 vaccine for malaria is a significant
stride in the fight against the disease. However, there are several challenges that need to be …

… because of malaria[ 5 ]. The recent development and phase 3 testing of the most advanced
malaria vaccine, RTS, S/AS01, indicates that malaria vaccine is moving into a new phase[ 6 ]. …

… to assess the impact of RTS,S, the world's first malaria vaccine, and resolve specific safety
… -up of the vaccine as soon as was possible. By April, 2021, about 1·8 million doses of RTS,S …

… Further evaluations of the benefit, risk, feasibility and cost-effectiveness of RTS,S are now
anticipated through policy and financing reviews at the global and national levels. …

… – punctuating that further enhancement of long-term immunity would be needed to produce
a feasible vaccine. The results of this small trial could not demonstrate any statistically …

… ,S/AS02A maintained protection during the 45-month surveillance period, and they highlight
the feasibility of developing an effective vaccine against malaria. In combination with other …

… of mortality impact, and to demonstrate feasibility of a four-dose vaccination schedule via
routine Expanded Programme of Immunization (EPI) schedules in endemic Africa [7]. The …

… The observation of high grade protection in humans overcame any doubts regarding the
feasibility of a pre-erythrocytic stage vaccine, and set a benchmark in the field of high-level (>90…

… malaria burden in children across Africa. Conditional on assumptions on price, coverage,
and vaccine properties, adding RTS,S to routine malaria … further consider feasibility of scaling …

… WHO-directed malaria vaccine implementation studies are … most advanced malaria vaccine
to date, the RTS,S vaccine. … on the feasibility of administering 4 doses of vaccine in children, …